范科米辛诱导的血小板缺血的发生率和危险因素:为期六年的现实研究
Yuanchao Zhu1, Lishuang Huang2, Jingjing Zhang3
1Department of Pharmacy, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application Beijing Hospital, Beijing, 100730, P.R. China.
BMC infectious diseases
|January 3, 2025
概括
香草素诱导的血小板缺血 (VIT) 影响3.3%的患者,通常发生在治疗9天后. 医务人员应监测出血情况,特别是在患有这种严重疾病多种风险因素的患者中.
科学领域:
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
- 临床医学 临床医学
背景情况:
- 药物诱导的血小板缺血是众所周知的各种药物的不良影响.
- 尽管它可能导致严重的出血并发症,但万科素诱导的血小板缺血 (VIT) 尚未得到充分的认可.
- 关于VIT的发病率,风险因素和临床表现的研究有限.
研究的目的:
- 为了确定VIT的发生和临床表现.
- 识别与VIT发展相关的风险因素.
- 为了评估VIT在现实世界患者队列中的发生率.
主要方法:
- 进行了一项回顾性病例控制研究.
- 从2018年1月至2023年12月期间接受静脉注射万科米辛治疗的患者收集了数据.
- 分析了发病率,康复率和风险因素.
主要成果:
- VIT的发病率为3.3% (42/1269),中位数发病时间为开始服用万科米辛后9天.
- 在停止使用万科米辛后的24名患者中发生了血小板恢复,平均9天.
- 对VIT的显著风险因素包括qSOFA评分≥2,脏疾病,万科米辛持续时间≥8天,血小板水平较低,BUN升高.
结论:
- 在万科米辛治疗期间,对出血症状的警至关重要.
- 患有多种风险因素 (≥3) 的患者需要加强对潜在VIT的监测.
- 早期识别和管理VIT至关重要,以防止严重的结果.
相关概念视频
Factors Affecting the Risk of Infection
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...


